APA (7th ed.) Citation

Yu, J., Luo, Y., Wang, L., Wang, T., Ye, M., Chen, J., . . . Yang, J. (2024). Effect of sustained measurable residue disease negativity and post‐remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults. Cancer Medicine, 13(10), . https://doi.org/10.1002/cam4.7310

Chicago Style (17th ed.) Citation

Yu, Jiechen, et al. "Effect of Sustained Measurable Residue Disease Negativity and Post‐remission Treatment Selection on the Prognosis of Acute Lymphoblastic Leukemia in Adults." Cancer Medicine 13, no. 10 (2024). https://doi.org/10.1002/cam4.7310.

MLA (9th ed.) Citation

Yu, Jiechen, et al. "Effect of Sustained Measurable Residue Disease Negativity and Post‐remission Treatment Selection on the Prognosis of Acute Lymphoblastic Leukemia in Adults." Cancer Medicine, vol. 13, no. 10, 2024, https://doi.org/10.1002/cam4.7310.